COLLPLANT APPOINTS DR. RUTI BEN SHLOMI TO ITS BOARD OF DIRECTORS FOLLOWING CLOSING OF LIGHTSOLVER ACQUISITION

CollPlant Biotechnologies Ltd. (Nasdaq: CLGN ) today announced the appointment of Dr. Ruti Ben Shlomi, Chief Executive Officer and Co-Founder of LightSolver Ltd. ("LightSolver"), to CollPlant's Board of Directors, effective immediately following the completion of CollPlant's acquisition of LightSolver, as announced on September 3, 2026.

LightSolver is pioneering a new generation of high performance computing based on the physics of light. Its proprietary Laser Processing Unit (LPU), an energy-efficient, pure photonic computing platform that uses coupled lasers to perform computation, is designed to accelerate computationally intensive workloads across scientific simulation, engineering, optimization and Physical AI.

Dr. Ruti Ben Shlomi commented, "I am honored to join CollPlant's Board of Directors as we begin this next chapter. The completion of this transaction creates an important opportunity to accelerate LightSolver's transition from technology validation to commercialization and help establish photonic computing as a new computing layer for some of the world's most demanding computational workloads. I look forward to working closely with the Board and executive team to as we advance this next phase of LightSolver's development and create long-term value for our shareholders."

Dr. Ruti Ben Shlomi is the CEO and Co-Founder of LightSolver. She is an expert physicist with over 15 years of experience spanning quantum, atomic, and molecular physics, photonic computing and technology leadership. Prior to co-founding LightSolver in 2020, Dr. Ben Shlomi conducted groundbreaking research at the Weizmann Institute of Science, where she built ultra-cold atom and cold ion systems to study complex quantum signatures. Earlier in her career, she served as a process engineer at Intel Corporation. Dr. Ben Shlomi holds a Ph.D. in Quantum and Atomic/Molecular Physics from the Weizmann Institute of Science, an M.Sc. in Physics from Ben-Gurion University of the Negev, and a B.Sc. in Biophysics from Bar-Ilan University.

About CollPlant CollPlant is a pioneering technology company operating at the forefront of both regenerative medicine and advanced high-performance computing. Following the strategic acquisition of LightSolver, CollPlant has expanded its footprint into the deep-tech sector, integrating a proprietary all-optical computing architecture known as the Laser Processing Unit (LPU). This bold diversification positions the Company to address some of the world's most computationally intensive workloads across aerospace, defense, and Physical AI, while continuing to drive its core biotech innovations. In the healthcare sector, CollPlant is ushering in a new era of medical solutions with a focus on 3D bioprinting of tissues and organs, tissue repair, and medical aesthetics. The Company's products are based on its recombinant human collagen produced with CollPlant's proprietary plant-based genetic engineering technology, addressing indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. For more information about Co...